angiotensin
ii
ang
ii
play
import
role
cardiomyocyt
hypertrophi
combin
effect
hepatocyt
growth
factor
hgf
ang
ii
cardiomyocyt
unknown
present
studi
design
determin
effect
hgf
cardiomyocyt
hypertrophi
explor
combin
effect
hgf
ang
ii
cardiomyocyt
hypertrophi
primari
cardiomyocyt
isol
neonat
rat
heart
cultur
vitro
cell
treat
ang
ii
alon
hgf
ngml
alon
ang
ii
plu
hgf
ngml
h
amount
h
leucin
incorpor
measur
evalu
protein
synthesi
mrna
level
heavi
chain
atrial
natriuret
factor
determin
realtim
pcr
evalu
presenc
fetal
phenotyp
gene
express
cell
size
cardiomyocyt
also
studi
ang
ii
increas
cardiomyocyt
hypertrophi
similar
ang
ii
treatment
hgf
promot
cardiomyocyt
hypertrophi
moreov
combin
ang
ii
ngml
hgf
clearli
induc
combin
prohypertrophi
effect
cardiomyocyt
present
studi
demonstr
first
time
novel
combin
effect
hgf
ang
ii
promot
cardiomyocyt
hypertrophi
myocardi
hypertrophi
defin
thicken
myocardium
result
decreas
size
chamber
heart
includ
left
right
ventricl
import
risk
factor
subsequ
cardiac
morbid
mortal
pathophysiolog
role
cardiomyocyt
hypertrophi
heart
diseas
intens
investig
howev
date
partial
understood
cardiac
hypertroph
growth
primari
respons
mechan
heart
reduc
stress
ventricular
wall
convent
view
suggest
cardiomyocyt
hypertrophi
compensatori
respons
increas
hemodynam
overload
lead
cardiac
diseas
howev
recent
find
genet
anim
model
myocardi
hypertrophi
well
human
studi
reveal
support
molecular
basi
wherebi
either
compensatori
maladapt
form
hypertrophi
exist
latter
lead
cardiac
failur
case
myocardi
infarct
hypertroph
respons
occur
cardiomyocyt
surviv
portion
ventricl
ventricular
dilat
follow
result
reorgan
myocardium
includ
cardiomyocyt
mesenchym
cell
combin
execut
respons
cardiomyocyt
stimul
neurohumor
factor
subsequ
intracellular
reactiv
cascad
system
process
entail
increas
protein
synthesi
well
size
architectur
rearrang
within
individu
cardiomyocyt
angiotensin
ii
ang
ii
central
product
reninwwwbjournalcombr
braz
j
med
biol
re
angiotensin
system
believ
one
import
regul
initi
posit
feedback
regul
cardiac
hypertroph
respons
cultur
cardiomyocyt
ang
ii
shown
directli
induc
gene
express
heavi
chain
atrial
natriuret
factor
anf
also
increas
protein
synthesi
protein
content
activ
angiotensin
receptor
detail
mechan
describ
recent
year
includ
involv
mitochondri
oxid
stress
autophagi
protein
kinas
nitric
oxid
focal
adhes
kinas
ampactiv
protein
kinas
fact
addit
ang
ii
larg
number
intracellular
extracellular
factor
affect
cardiomyocyt
hypertrophi
vivo
moreov
influenc
factor
ang
iiinduc
cardiomyocyt
hypertrophi
larg
unknown
present
studi
hypothes
may
crosstalk
ang
ii
hepatocyt
growth
factor
hgf
cardiomyocyt
hypertrophi
hgf
paracrin
cellular
growth
motil
morphogen
factor
initi
isol
fibroblast
shown
stimul
motil
epitheli
cell
wide
rang
effect
mani
biolog
process
specif
hgf
act
primarili
epitheli
cell
endotheli
cell
hematopoiet
progenitor
cell
shown
major
role
embryon
organ
develop
adult
organ
regener
wound
heal
recent
year
impact
hgf
heart
cardiomyocyt
gradual
uncov
hgf
protect
heart
ischemicreperfus
injuri
attenu
cardiac
remodel
improv
angiogenesi
induc
endotheli
progenitor
cell
mobil
studi
first
determin
effect
singl
treatment
ang
ii
hgf
cardiomyocyt
examin
whether
combin
treatment
ang
ii
hgf
differ
factor
administ
individu
newborn
spraguedawley
rat
g
suppli
anim
center
guangzhou
medic
univers
rat
hous
use
accord
institut
guidelin
anim
care
guid
anim
care
nation
institut
health
dulbecco
modifi
eagl
medium
dmem
fetal
bovin
serum
fb
trizol
purchas
gibco
brl
usa
trypsin
obtain
amersco
usa
alphasarcomer
actin
purchas
santa
cruz
biotechnolog
usa
sybr
greenpcr
master
mix
obtain
appli
biosystem
usa
thermo
scriptrtpcr
kit
purchas
invitrogen
usa
h
leucin
leu
obtain
china
institut
atom
energi
china
recombin
ang
ii
hgf
purchas
sigma
germani
rat
neonat
ventricular
cardiomyocyt
prepar
previous
describ
modif
cell
suspend
dmem
contain
fb
mm
bromodeoxyuridin
plate
either
glass
coverslip
polystyrenetr
petri
dish
cell
cultur
co
incub
h
pulsat
cardiomyocyt
observ
invert
biolog
microscop
addit
cardiomyocyt
fix
stain
immunohistochem
method
use
actin
antibodi
puriti
cardiomyocyt
approxim
cardiomyocyt
medium
chang
serumfre
dmem
h
cardiomyocyt
treat
differ
concentr
ang
ii
hgf
ngml
h
order
explor
appropri
concentr
factor
base
experi
identifi
optim
treatment
regimen
cardiomyocyt
divid
four
group
control
group
pb
hgftreat
group
ngml
ang
iitreat
group
hgf
ngml
plu
ang
ii
treat
group
cell
treat
agent
h
tritiat
leucin
h
leu
incorpor
studi
perform
previous
describ
investig
effect
treatment
total
protein
synthesi
cell
seed
plate
x
cellswel
treat
hgf
ngml
ang
ii
hgf
ngml
plu
ang
ii
describ
preced
section
cell
puls
h
leu
bqml
h
end
treatment
end
incub
cell
wash
three
time
icecold
pb
disrupt
addit
sodium
dodecyl
sulfat
n
naoh
solubil
cell
lysat
ad
ml
scintil
fluid
incorpor
h
leu
protein
determin
scintil
count
incorpor
report
ratio
h
leu
incorporationnumb
cell
cell
treat
hgf
ngml
ang
ii
hgf
ngml
plu
ang
ii
h
wash
icecold
pb
buffer
total
rna
extract
cell
use
trizol
rna
revers
transcrib
cdna
use
thermo
scriptrtpcr
realtim
pcr
perform
use
appli
biosystem
fast
realtim
pcr
system
sybr
premix
ex
taq
mixtur
specif
primer
sangon
china
pcr
assay
initi
denatur
step
follow
amplif
cycl
anneal
wwwbjournalcombr
braz
j
med
biol
re
twostep
method
final
melt
curv
analysi
perform
data
evalu
appli
biosystem
softwar
follow
primer
design
primer
express
softwar
appli
biosystem
use
anf
gca
aac
tga
ggg
sens
atc
ttt
tgc
gat
antisens
agt
taa
agg
tga
agg
sens
ggc
ttc
aca
ggc
antisens
glyceraldehyd
dehydrogenas
gapdh
agt
caa
cgg
att
tgg
tgg
sens
ctt
ctc
cat
ggt
ggt
gaa
antisens
gapdh
use
intern
control
amount
target
defin
method
cardiomyocyt
seed
plate
cultur
h
treatment
hgf
ngml
ang
ii
hgf
ngml
plu
ang
ii
h
cell
digest
edtatrypsin
min
fb
use
termin
reaction
averag
cell
size
determin
use
imag
j
softwar
http
rsbinfonihgovijdownloadhtml
previous
describ
averag
cell
size
determin
observ
cell
cellswel
x
well
data
report
mean
sd
differ
evalu
twotail
student
ttest
group
oneway
analysi
varianc
anova
follow
tukey
post
hoc
test
group
use
spss
softwar
version
usa
statist
signific
set
p
shown
tabl
ang
ii
caus
slight
signific
increas
h
leu
incorpor
compar
control
vs
cpmwell
respect
p
howev
concentr
ang
ii
mrna
level
anf
primari
cardiomyocyt
chang
ang
ii
administ
higher
concentr
h
leu
incorpor
increas
cpmwell
approxim
higher
control
group
p
addit
concentr
ang
ii
also
significantli
enhanc
mrna
level
anf
p
p
ang
ii
concentr
increas
amount
h
leu
incorpor
increas
approxim
compar
control
group
vs
cpmwell
respect
p
mrna
level
anf
increas
p
p
respect
highest
concentr
ang
ii
test
increas
h
leu
incorpor
slightli
vs
cpmwell
respect
p
moreov
concentr
ang
ii
mrna
level
anf
increas
respect
therefor
chose
optim
concentr
ang
ii
subsequ
experi
sought
determin
effect
differ
concentr
hgf
h
leu
incorpor
well
mrna
level
anf
primari
cardiomyocyt
shown
tabl
administr
ngml
hgf
significantli
increas
h
leu
incorpor
cardiomyocyt
cpmwell
approxim
higher
control
group
p
moreov
hgf
concentr
also
significantli
p
enhanc
mrna
level
anf
hgf
concentr
increas
ngml
h
leu
incorpor
higher
compar
control
vs
cpmwell
respect
p
moreov
anf
mrna
level
also
increas
respect
p
interestingli
highest
concentr
hgf
ngml
increas
h
leu
incorpor
anf
mrna
level
compar
lower
concentr
hgf
ngml
therefor
chose
ngml
optim
concentr
hgf
subsequ
experi
next
investig
whether
hgf
ang
ii
combin
effect
cardiomyocyt
ang
ii
hgf
combin
induc
signific
increas
h
leu
incorpor
anf
mrna
mrna
level
figur
interestingli
hgfinduc
cardiomyocyt
hypertrophi
even
greater
ang
iiinduc
hypertrophi
figur
compar
hgf
ngml
ang
ii
group
combin
treatment
hgf
ngml
ang
ii
increas
h
leu
incorpor
even
h
figur
p
similarli
combin
treatment
cardiomyocyt
hgf
ngml
ang
ii
significantli
upregul
mrna
level
anf
figur
figur
compar
separ
treatment
hgf
ngml
ang
ii
alon
time
point
also
determin
effect
hgf
ang
ii
cardiomyocyt
cell
size
compar
control
group
hgf
ngml
treat
group
ang
ii
treat
group
show
increas
cell
size
figur
combin
treatment
hgf
ang
ii
increas
cell
size
cardiomyocyt
figur
studi
first
directli
assess
whether
combin
effect
hgf
ang
ii
cardiomyocyt
hypertrophi
base
increas
h
leu
incorpor
increas
anf
mrna
express
increas
cell
size
primari
cardiomyocyt
conclud
hgf
ang
ii
combin
effect
neonat
cardiomyocyt
hypertrophi
addit
also
demonstr
first
time
hgf
alon
potent
induc
cultur
neonat
cardiomyocyt
hypertrophi
studi
first
found
hgf
could
induc
cardiomyocyt
hypertrophi
surpris
hgfinduc
cardiomyocyt
hypertrophi
even
greater
ang
iiinduc
hypertrophi
figur
presenc
hgf
receptor
cardiomyocyt
first
confirm
akiyama
et
al
subsequ
sever
independ
report
demonstr
protect
effect
hgf
myocardi
infarct
vivo
howev
yet
underli
mechan
prohypertrophi
cardiomyocyt
clear
moreov
result
vivo
experi
exclud
possibl
hgf
treatment
stimul
cardiac
fibroblast
therebi
releas
factor
induc
hypertrophi
surround
cardiomyocyt
patholog
cardiomyocyt
hypertrophi
character
increas
cardiomyocyt
size
also
cardiomyocyt
gene
reprogram
shown
enhanc
express
fetal
phenotyp
gene
skelet
anf
studi
evalu
cell
hypertrophi
determin
h
leu
incorpor
averag
cell
size
well
anf
mrna
level
base
variou
paramet
clearli
shown
hgf
directli
induc
cardiomyocyt
hypertrophi
note
nakamura
et
al
demonstr
interfer
administ
hgf
cardiomyopathi
remodel
hamster
heart
author
found
direct
neg
effect
hgf
transcript
level
anf
present
studi
show
induct
effect
hgf
anf
level
agreement
previou
report
consid
dispar
might
due
speci
differ
base
find
sought
determin
prohypertrophi
effect
hgf
may
occur
sinc
common
caus
cardiomyocyt
hypertrophi
hypertens
sinc
increas
ang
ii
level
hypertens
critic
prohypertrophi
trigger
next
explor
whether
might
associ
hgf
ang
ii
cardiomyocyt
importantli
found
combin
effect
hgf
ang
ii
cardiomyocyt
hypertrophi
role
ang
ii
regul
cardiovascular
system
normal
patholog
condit
well
document
well
accept
ang
ii
direct
prohypertrophi
factor
cardiomyocyt
moreov
evid
ang
ii
relat
protein
tumor
necrosi
play
key
role
cardiac
fibroblast
growth
collagen
deposit
follow
myocardi
infarct
addit
heparin
highli
sulfat
glycosaminoglycan
wide
use
inject
anticoagul
found
potent
inhibit
ang
iimedi
cardiomyocyt
hypertrophi
famili
cytokin
also
report
contribut
ang
iiinduc
cardiomyocyt
hypertrophi
howev
best
knowledg
report
date
combin
effect
ang
ii
protein
cardiomyocyt
hypertrophi
importantli
sinc
cardiomyocyt
hypertrophi
relat
pathophysiolog
mechan
mani
cardiovascular
diseas
find
studi
may
bring
new
focu
hgf
treat
cardiovascular
diseas
one
limit
studi
molecular
mechan
underli
combin
effect
ang
ii
hgf
cardiomyocyt
hypertrophi
remain
elucid
report
postinfarct
hgf
gene
therapi
result
substanti
cardiomyoct
hypertrophi
edg
infarct
tissu
accompani
overexpress
hgf
receptor
cmet
transmembran
tyrosin
kinas
hgf
activ
rasrafmekerk
signal
pathway
therebi
contribut
myocardi
hypertrophi
cmet
also
receptor
scatter
factor
sf
activ
cmet
hgfsf
elicit
varieti
cellular
respons
includ
prolifer
migrat
invas
branch
morphogenesi
process
associ
sever
signal
pathway
src
moreov
signal
pathway
also
contribut
ang
iiinduc
hypertrophi
aoki
et
al
shown
erk
pathway
import
role
ang
iiinduc
cardiac
hypertrophi
moreov
src
pathway
also
report
vital
control
ang
iiinduc
cardiac
hypertrophi
therefor
may
difficult
determin
exact
underli
molecular
mechan
combin
effect
hgf
ang
ii
cardiomyocyt
hypertrophi
converg
point
hgf
ang
ii
need
elucid
futur
experi
studi
provid
first
evid
hgf
ang
ii
administ
combin
induc
cardiomyocyt
hypertrophi
find
support
chang
observ
protein
synthesi
presenc
fetal
phenotyp
gene
express
anf
increas
cell
size
ultrastructur
chang
neonat
cardiomyocyt
result
may
help
improv
manag
treatment
patient
cardiac
hypertrophi
